Healthcare Triangle, Inc. (HCTI) Revenue History
Annual and quarterly revenue from 2019 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
HCTI Revenue Growth
Revenue Breakdown (FY 2022)
HCTI's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
HCTI Revenue Analysis (2019–2024)
As of May 8, 2026, Healthcare Triangle, Inc. (HCTI) generated trailing twelve-month (TTM) revenue of $12.9 million, reflecting explosive growth of +44.6% year-over-year. The most recent quarter (Q3 2025) recorded $3.5 million in revenue, down 1.9% sequentially.
Looking at the longer-term picture, HCTI's 5-year compound annual growth rate (CAGR) stands at -16.5%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $45.9 million in 2022.
Revenue diversification analysis shows HCTI's business is primarily driven by Software Services (54%), Managed Services And Support (35%), and Platform Services (11%). With over half of revenue concentrated in Software Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HIMS (+59.0% YoY), HCAT (+1.5% YoY), and MTEX (-9.2% YoY), HCTI has underperformed the peer group in terms of revenue growth. Compare HCTI vs HIMS →
HCTI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HCTICurrent | $13M | +44.6% | -16.5% | -40.6% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% | |
 HCAT | $311M | +1.5% | +10.5% | -51.7% | |
 MTEX | $118M | -9.2% | -5.7% | 1.2% | |
 VEEV | $3.2B | +16.3% | +16.9% | 28.7% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% |
HCTI Historical Revenue Data (2019–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $11.7M | -64.8% | $2.9M | 24.7% | $-4,751,000 | -40.6% |
| 2023 | $33.2M | -27.6% | $6.8M | 20.4% | $-11,348,000 | -34.2% |
| 2022 | $45.9M | +30.1% | $11.3M | 24.6% | $-10,416,000 | -22.7% |
| 2021 | $35.3M | +12.5% | $10.5M | 29.8% | $-5,359,049 | -15.2% |
| 2020 | $31.3M | +9.1% | $8.6M | 27.4% | $1.2M | 3.8% |
| 2019 | $28.7M | - | $5.8M | 20.4% | $1.7M | 5.8% |
See HCTI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HCTI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HCTI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHCTI — Frequently Asked Questions
Quick answers to the most common questions about buying HCTI stock.
Is HCTI's revenue growth accelerating or slowing?
HCTI revenue is accelerating at +44.6% year-over-year, exceeding the 5-year CAGR of -16.5%. TTM revenue reached $13M. Growth momentum has increased versus prior periods.
What is HCTI's long-term revenue growth rate?
Healthcare Triangle, Inc.'s 5-year revenue CAGR of -16.5% reflects the sustained expansion pattern. Current YoY growth of +44.6% is above this long-term average.
How is HCTI's revenue distributed by segment?
HCTI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2024 are available for download. Segment mix reveals concentration and diversification trends.